Intellia Therapeutics Inc

NASDAQ: NTLA
$21.17
-$0.36 (-1.7%)
Closing price April 24, 2024
Intellia Therapeutics Inc is at the forefront of genome editing, pioneering the development of treatments with the potential to cure diseases. Their work includes groundbreaking in vivo programs like NTLA-2001, targeting transthyretin amyloidosis, and others aimed at hereditary angioedema and alpha-1 antitrypsin deficiency. Beyond these, Intellia is exploring engineered cell therapies for cancer and autoimmune diseases, leveraging advanced CRISPR/Cas9 technology. Partnerships with leading biotech firms enhance their efforts in hemophilia and CAR-T cell therapies, underscoring their commitment to revolutionizing medicine. Founded in 2014, Intellia's home base is in Cambridge, Massachusetts.

Wednesday's Top Analyst Upgrades and Downgrades: Charles Schwab, GE, GitLab, Home Depot, Match, SoFi, United Airlines and More
Wednesday's top analyst upgrades and downgrades included Academy Sports and Outdoors, Asana, Charles Schwab, Estee Lauder, General Electric, GitLab, Home Depot, Match, Ovintiv, SoFi Technologies and...
Lee Jackson
Published:
Last Updated:

Wednesday's Top Analyst Upgrades and Downgrades: Amazon, Caesars, Dollar Tree, DraftKings, IBM, Lyft, Marathon Oil, McDonald's, Starbucks, Target and More
Wednesday's top analyst upgrades and downgrades included Amazon.com, Blackstone, Caesars Entertainment, Dollar Tree, DraftKings, GlobalFoundries, IBM, Lyft, Marathon Oil, McDonald's, Palo Alto...
Lee Jackson
Published:

Thursday's Top Analyst Upgrades and Downgrades: AutoZone, CrowdStrike, Estee Lauder, Morgan Stanley, Nvidia, Western Digital and More
Thursday’s top analyst upgrades and downgrades included AutoZone, CrowdStrike, Estee Lauder, Morgan Stanley, Nvidia and Western Digital.
Lee Jackson
Published:

Friday's Top Analyst Upgrades and Downgrades: Amgen, AutoZone, Boeing, Dollar General, Etsy, FedEx, Unity Software, Warner Bros. Discovery and More
Friday's top analyst upgrades and downgrades included Acadia Pharmaceuticals, Accenture, Amgen, AutoZone, Azek, Boeing, Dollar General, Etsy, Fidelity National Information Services, FedEx, NexTier...
Lee Jackson
Published:

Tuesday's Top Analyst Upgrades and Downgrades: Apple, Continental Resources, Bilibili, Eaton, Hershey, Meta Platforms, Nio, NOV, PayPal, Southern Company and More
Tuesday's top analyst upgrades and downgrades included Apple, Continental Resources, Bilibili, Eaton, Hershey, Meta Platforms, Nio, NOV, PayPal and Southern Company.
Lee Jackson
Published:
Last Updated:

Friday Afternoon Analyst Upgrades and Downgrades: Barrick Gold, Newmont, Salesforce and More
Friday afternoon's analyst upgrades and downgrades included Barrick Gold, Canadian National Railway, Community Health Systems, Editas Medicine, Intellia Therapeutics, Newmont and Salesforce.com.
Chris Lange
Published:

Why Cramer Thinks Companies Should Not Aspire to Meme Stock Status
24/7 Wall St. takes a look at famed market personality Jim Cramer’s latest buy and sell recommendations and overall analysis.
Chris Lange
Published:

Friday's Top Analyst Upgrades and Downgrades: Biogen, CME, Dropbox, DocuSign, Nvidia, Tilray and More
Friday's top analyst upgrades and downgrades included Biogen, CME, Dropbox, DocuSign, Nvidia, Ping Identity, Signet Jewelers and Tilray.
Chris Lange
Published:

Etsy, Monster Beverage, Nokia and More Friday Afternoon Analyst Calls
24/7 Wall St. looks at some big analyst calls that we have seen so far on Friday, including Etsy, Fate Therapeutics, Intellia, Ionis, Monster Beverage and more.
Chris Lange
Published:

Domino's, Editas, Roblox, Teva, US Steel and More Tuesday Afternoon Analyst Calls
24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including Domino’s Pizza, Editas Medicine, Roblox, Teva Pharmaceutical Industries and U.S. Steel.
Chris Lange
Published: